Loading clinical trials...
Loading clinical trials...
Hyperbaric Oxygen Therapy in Complex Regional Pain Syndrome: a Randomised Controlled Trial
The aim of the study is to investigate the efficacy of hyperbaric oxygen therapy as an adjunct in the management of severe complex regional pain syndrome.
Randomised controlled trial (RCT) with delayed start of therapy (delayed-start / wait-list). The intervention (early) group initiates therapy immediately after baseline (T0). The control (delayed) group initiates therapy only after the first follow-up (T1). The primary inter-group comparison is planned at time T1 (4-6 weeks after T0). In addition, for the delayed group, the post-treatment evaluation of T2 (4-6 weeks after T1) is supportive of the effect.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, Czechia
Municipal Hospital Ostrava Fifejdy
Ostrava, Moravian-Silesian Region, Czechia
Start Date
April 1, 2026
Primary Completion Date
April 1, 2028
Completion Date
April 1, 2029
Last Updated
March 3, 2026
60
ESTIMATED participants
Early hyperbaric oxygen therapy (HBOT)
PROCEDURE
Delayed hyperbaric oxygen therapy (HBOT)
PROCEDURE
Lead Sponsor
University Hospital Ostrava
NCT07473635
NCT04379115
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions